Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
132M
-
Number of holders
-
98
-
Total 13F shares, excl. options
-
34.8M
-
Shares change
-
+436K
-
Total reported value, excl. options
-
$578M
-
Value change
-
+$6.72M
-
Put/Call ratio
-
0.02
-
Number of buys
-
40
-
Number of sells
-
-43
-
Price
-
$16.62
Significant Holders of RAPT Therapeutics, Inc. - Common Stock (RAPT) as of Q3 2023
108 filings reported holding RAPT - RAPT Therapeutics, Inc. - Common Stock as of Q3 2023.
RAPT Therapeutics, Inc. - Common Stock (RAPT) has 98 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.8M shares
of 132M outstanding shares and own 26.33% of the company stock.
Largest 10 shareholders include FMR LLC (4.5M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.54M shares), Column Group LLC (2.68M shares), BlackRock Inc. (2.32M shares), VANGUARD GROUP INC (2.02M shares), PERCEPTIVE ADVISORS LLC (1.92M shares), Deep Track Capital, LP (1.5M shares), GREAT POINT PARTNERS LLC (1.46M shares), STATE STREET CORP (1.41M shares), and T. Rowe Price Investment Management, Inc. (1.25M shares).
This table shows the top 98 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.